March 18, 2026

The Infusion Providers Alliance (IPA) submitted comments for the record ahead of the House Energy & Commerce Health Subcommittee’s hearing, Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape. IPA’s comments emphasized the critical role that non-hospital, community-based infusion providers play in expanding patient access to high-quality, lower-cost care for individuals living with complex and chronic conditions.

IPA urged policymakers to prioritize policies that preserve access to provider-administered Part B therapies in community-based settings. Specifically, IPA called on Congress to advance H.R. 4299, the Protecting Patient Access to Cancer and Complex Therapies Act.

H.R. 4299 would address looming reimbursement cuts for providers administering medications subject to Maximum Fair Prices (MFPs) under the Medicare Drug Price Negotiation Program (MDPNP). Without a legislative fix, these reductions could threaten patient access to more convenient, lower-cost community-based care.

The legislation offers a targeted solution by replacing provider reimbursement cuts with manufacturer rebates, ensuring negotiated savings can be realized without undermining provider stability or patient access. Advancing H.R. 4299 would also help strengthen provider competition and serve as an important counterweight to ongoing hospital consolidation of physician practices and other independent providers.

Read IPA’s comments to the House Energy & Commerce Committee.

About the Infusion Providers Alliance

The Infusion Providers Alliance (IPA) is committed to protecting the integrity of the provider-patient relationship by empowering providers and patients to choose the most appropriate treatment together. We advocate for policies that ensure timely and adequate patient access to high quality care in IPA members’ convenient, community-based, non-hospital settings. IPA members operate over 1,000 in-office or stand-alone ambulatory infusion centers across 45 states nationwide, delivering value to the health care system and improved outcomes to patients.

All inquiries should be emailed to ewarren@infusionprovidersalliance.org.